MAM
CASC

Meeder Asset Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Meeder Asset Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,014
Closed -$4K – 1845
2017
Q2 		$4K Buy
+1,014
New +$4K ﹤0.01% 1298